MX1 ASX · Health Care

Micro-X Ltd

Announcements, last 12 months
90
Price sensitive, last 12 months
19
Followed on InvestorPA
Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released Headline Actions
MX1 - Notice Under Section 708A(5) of the Corporations Act
Application for quotation of securities - MX1
Notification of cessation of securities - MX1
MX1 - Notice of 2026 Annual General Meeting and Proxy Form
Change of Director's Interest Notice - Patrick O'Brien
Change of Director's Interest Notice - Andrew Hartmann
Change of Director's Interest Notice - Jim McDowell
Change of Director's Interest Notice - Ilona Meyer
Notification regarding unquoted securities - MX1
MX1 - Convertible Note Funding Update

Sign in to see all MX1 announcements.

Guidance history

28 Aug 2026 Micro-X Ltd expects to achieve annualized cost savings of more than $3 million in FY27.
3 Aug 2026 Micro-X Ltd secures $8 million in convertible note financing to support strategic initiatives.
31 Jul 2026 Micro-X expects approximately $2 million of the net FY26 Research and Development Tax Incentive rebate to flow through operating activities in October 2026.

Sign in to see the full guidance history.

Most followed in Health Care

  • PME Pro Medicus Ltd
  • AHC Austco Healthcare Ltd
  • CSL CSL Ltd
  • RMD Resmed Inc
  • TLX TELIX Pharmaceuticals Ltd
  • CGS Cogstate Ltd
  • ALC Alcidion Group Ltd
  • CSX Cleanspace Holdings Ltd
Follow MX1 to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.
Sign in